Table Of Contents

1. Introduction
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Middle East And Africa Hemostats Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered
2. Market Segmentation
2.1. Markets Covered
2.2. Years Considered For The Study
2.3. Currency And Pricing
2.4. Research Methodology
2.5. Primary Interviews With Key Opinion Leaders
2.6. Secondary Source
2.7. Assumptions
3. Market Overview
3.1. Drivers
3.1.1. Chronic Conditions And Aging Population Leading To Increase In Number Of Surgical Procedures
3.1.2. Technological Advancements
3.1.3. Increasing Number Of Minimally Invasive Surgeries
3.1.4. Improving Healthcare Infrastructure And Increasing Healthcare Spending
3.2. Restraints
3.2.1. Reluctance Of Surgeons Towards New Products
3.2.2. Weak Reimbursement
3.3. Opportunities
3.3.1. Unmet Medical Needs
3.3.2. Emerging Market
3.4. Challenges
3.4.1. Development Of Substitute Products
3.4.2. Limitations Of Hemostatic Agents In Achieving Hemostasis
4. Executive Summary
5. Premium Insights
6. Middle East And Africa Hemostats Market, By Type
6.1. Overview
6.2. Thrombin Based Hemostats
6.3. Combination Agent Hemostats
6.4. Oxidized Regenerated Cellulose Based Hemostats
6.5. Gelatin Based Hemostats
6.6. Collagen Based Hemostats
7. Middle East And Africa Hemostats Market, By Application
7.1. Overview
7.2. Wound Closure
7.3. Surgical Hemostats
8. Middle East And Africa Hemostats Market, By Distribution Channel
8.1. Overview
8.1.1. Direct Tenders
8.1.2. Retail
9. Middle East And Africa Hemostats Market, By End User
9.1. Overview
9.2. Middle East And Africa Hemostats Market; Hospitals
9.3. Middle East And Africa Hemostats Market; Ambulatory Centers
9.4. Middle East And Africa Hemostats Market; Community Healthcare
9.5. Middle East And Africa Hemostats Market; Clinics
10. Middle East And Africa Hemostats Market, By Geography
10.1. Middle East And Africa
10.1.1. South Africa
10.1.2. Rest Of Mea
11. Middle East And Africa Hemostats Market, Company Landscape
11.1. Company Share Analysis; Middle East And Africa
12. Company Profiles
12.1. Ethicon Us, Llc (Subsidiary Of Johnson & Johnson Services, Inc)
12.1.1. Company Overview
12.1.2. Revenue Analysis
12.1.3. Product Portfolio
12.1.4. Recent Developments
12.2. Pfizer
12.2.1. Company Overview
12.2.2. Revenue Analysis
12.2.3. Product Portfolio
12.2.4. Recent Developments
12.3. C R Bard
12.3.1. Company Overview
12.3.2. Revenue Analysis
12.3.3. Product Portfolio
12.3.4. Recent Developments
?
12.4. Baxter
12.4.1. Company Overview
12.4.2. Revenue Analysis
12.4.3. Product Portfolio
12.4.4. Recent Developments
12.5. Vascular Solutions, Inc (Acquired By Teleflex Incorporated)
12.5.1. Company Overview
12.5.2. Revenue Analysis
12.5.3. Product Portfolio
12.5.4. Recent Developments
12.6. B. Braun Melsungen Ag
12.6.1. Company Overview
12.6.2. Revenue Analysis
12.6.3. Product Portfolio
12.6.4. Recent Developments
12.7. Curamedical B.V.
12.7.1. Company Overview
12.7.2. Company Snapshot
12.7.3. Product Portfolio
12.7.4. Recent Developments
12.8. Axio Biosolutions Private Limited
12.8.1. Company Overview
12.8.2. Company Snapshot
12.8.3. Product Portfolio
12.8.4. Recent Developments
12.9. Anika Therapeutics, Inc.
12.9.1. Company Overview
12.9.2. Revenue Analysis
12.9.3. Product Portfolio
12.9.4. Recent Developments
12.10. Aegis Lifesciences
12.10.1. Company Overview
12.10.2. Revenue Analysis
12.10.3. Product Portfolio
12.10.4. Recent Developments
12.11. Cryolife, Inc.
12.11.1. Company Overview
12.11.2. Revenue Analysis
12.11.3. Product Portfolio
12.11.4. Recent Developments
12.12. Gelita Ag
12.12.1. Company Overview
12.12.2. Company Snapshot
12.12.3. Product Portfolio
12.12.4. Recent Developments
12.13. Hemostasis, Llc
12.13.1. Company Overview
12.13.2. Company Snapshot
12.13.3. Product Portfolio
12.13.4. Recent Developments
12.14. Medtrade Products Limited
12.14.1. Company Overview
12.14.2. Company Snapshot
12.14.3. Product Portfolio
12.14.4. Recent Developments
?
12.15. Stryker
12.15.1. Company Overview
12.15.2. Revenue Analysis
12.15.3. Product Portfolio
12.15.4. Recent Developments
12.16. Arch Therapeutics, Inc.
12.16.1. Company Overview
12.16.2. Revenue Analysis
12.16.3. Product Portfolio
12.16.4. Recent Developments
12.17. Mallinckrodt
12.17.1. Company Overview
12.17.2. Revenue Analysis
12.17.3. Product Portfolio
12.17.4. Recent Developments
12.18. Altaylar Medical
12.18.1. Company Overview
12.18.2. Company Snapshot
12.18.3. Product Portfolio
12.18.4. Recent Developments
12.19. Integra Lifesciences Corporation
12.19.1. Company Overview
12.19.2. Revenue Analysis
12.19.3. Product Portfolio
12.19.4. Recent Developments
?
12.20. Starch Medical
12.20.1. Company Overview
12.20.2. Company Snapshot
12.20.3. Product Portfolio
12.20.4. Recent Developments
13. Related Reports